Cloud Pharmaceuticals
Rtp, US · Founded 2009 · Delaware corporation
Founders & leadership
SK
Shahar KienanExecutive
LH
Lawrence HusickExecutive
LL
Lyle LohmeyerExecutive
ER
Edwin R AddisonChief Executive Officer
DV
Don Van DykeExecutive
LA
Lawrence A HusickNamed on SEC filing
KS
Kenneth SorensenNamed on SEC filing
Board
RA
Rob ArmstrongBoard director
MS
Mike SikoraBoard director
MB
Mike BrennanBoard director
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 4 rounds · 2011–2015
▶$350KraisedFeb 2016 · 5 investors · PharmaceuticalsRule 506(b)
▶$350KraisedFeb 2016 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Shahar KienanExecutive Officer, Director
- Rob ArmstrongDirector
- Lawrence HusickExecutive Officer, Director
- Mike SikoraDirector
- Lyle LohmeyerExecutive Officer
- Edwin R AddisonExecutive Officer, Director
- Mike BrennanDirector
- Don Van DykeExecutive Officer
- Offering amount
- $5M
- Amount sold
- $350K
- Minimum investment
- $25K
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$225KraisedJul 2014 · 3 investors · PharmaceuticalsRule 506(b)
▶$225KraisedJul 2014 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Edwin R AddisonExecutive Officer, Director
- Lawrence A HusickExecutive Officer, Director
- Mike BrennanDirector
- Shahar KienanExecutive Officer
- Kenneth SorensenDirector
- Mike SikoraDirector
- Offering amount
- $2M
- Amount sold
- $225K
- Sales commissions
- $22.5K
- Placement agents
- Kenneth A Sorensen
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2009
- Federal exemptions
- 06b
▶$307KraisedJul 2014 · 14 investors · PharmaceuticalsRule 506(b)
▶$307KraisedJul 2014 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mike SikoraDirector
- Edwin R AddisonExecutive Officer, Director
- Lawrence A HusickExecutive Officer, Director
- Kenneth SorensenDirector
- Mike BrennanDirector
- Shahar KienanExecutive Officer
- Offering amount
- $2M
- Amount sold
- $307K
- First sale
- Oct 2012
- Incorporated
- Corporation, Delaware, 2009
- Federal exemptions
- 06b
▶$690KraisedJul 2014 · 19 investors · PharmaceuticalsRule 506(b)
▶$690KraisedJul 2014 · 19 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mike SikoraDirector
- Mike BrennanDirector
- Shahar KienanExecutive Officer
- Kenneth SorensenDirector
- Lawrence A HusickExecutive Officer, Director
- Edwin R AddisonExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $690K
- First sale
- Jun 2011
- Incorporated
- Corporation, Delaware, 2009
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cloud Pharmaceuticals raised?
- Cloud Pharmaceuticals has disclosed $1.6M raised across 4 rounds.
- Where is Cloud Pharmaceuticals headquartered?
- Cloud Pharmaceuticals is headquartered in Rtp, US.